An evidence mapping and analysis of registered COVID-19 clinical trials in China
Lu L, Li F, Wen H, Ge S, Zeng J, Luo W, Wang L, Tang C, Xu N. An evidence mapping and analysis of registered COVID-19 clinical trials in China. BMC Medicine 2020, 18: 167. PMID: 32493331, PMCID: PMC7268588, DOI: 10.1186/s12916-020-01612-y.Peer-Reviewed Original ResearchConceptsCOVID-19 clinical trialsCurrent Control TrialsClinical Trials RegistryNational Research RegisterTraditional Chinese medicinePrimary outcomeTrials RegistryClinical trialsAntiviral drugsCOVID-19 nucleic acid testInternational Clinical Trials Registry PlatformAustralian Clinical Trials RegistryClinical Trials Registry PlatformChinese Clinical Trial RegistryEvidence mappingPilot studyPhase 4 trialTrials Registry PlatformNucleic acid testCOVID-19 trialsData monitoring committeePublic Health DivisionMedian sample sizeBiological agentsType of intervention